Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12144802
Pharmaceutical compositions of roflumilast and solvents capable of dissolving high amounts of the drug
granted -
US 12144812
Formulations of pyrimidine cyclohexyl glucocorticoid receptor modulators
granted -
US 12144788
Visual cycle modulators
granted -
US 12145922
Selective D3 dopamine receptor agonists and methods of their use
granted -
US 12144890
Manufacturing of bupivacaine multivesicular liposomes
granted -
US 12144881
Cosmetic composition containing α-mangostin, method for preparation, and uses thereof
granted -
US 12145939
Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators
granted -
US 12144876
Security mechanisms for radiopharmaceutical elution system and elution process
granted -
US 12144864
Tubulysins and protein-tubulysin conjugates
granted -
US 12145925
Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer
granted -
US 12144868
Muscle targeting complexes and uses thereof for treating dystrophinopathies
granted -
US 12144867
Muscle targeting complexes and uses thereof for treating dystrophinopathies
granted -
US 12144815
Use of aprepitant for treating Alzheimer's disease
granted -
US 12144813
PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer
granted -
WO 2024233379
INHIBITEUR DE BTK POUR LE TRAITEMENT DE LA SCLÉROSE EN PLAQUES
granted -
WO 2024233374
COMBINAISON D'UN INHIBITEUR DE BTK ET D'UN ESTER D'ACIDE FUMARIQUE DESTINÉE À ÊTRE UTILISÉE DANS LE TRAITEMENT DE LA SCLÉROSE EN PLAQUES
granted -
US 12139522
T-cells comprising two different chimeric antigen receptors and uses thereof
granted -
US 12138312
Cell-penetrating peptides for antisense delivery
granted -
US 12138274
Compositions and methods for the treatment of peripheral artery disease and cardiopulmonary diseases
granted -
US 12138243
Antiviral use of FABP4 modulating compounds
granted -
US 12138325
Dental composition
granted -
US 12139528
Treating refractory migraine
granted -
US 12139709
Antisense oligomers and methods of using the same for treating diseases associated with the acid alpha-glucosidase gene
granted -
US 12139764
Systems and methods for characterizing and treating breast cancer
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.